161 related articles for article (PubMed ID: 3876611)
21. [Cellular immunity in rheumatoid arthritis. Effect of therapy].
Roux H; Mercier P; Jeandel P; Brouillet-Gabriel M; Serratrice G
Rev Rhum Mal Osteoartic; 1977 May; 44(5):331-4. PubMed ID: 329399
[TBL] [Abstract][Full Text] [Related]
22. Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.
Messner RP; Lindström FD; Williams RC
J Clin Invest; 1973 Dec; 52(12):3046-56. PubMed ID: 4584345
[TBL] [Abstract][Full Text] [Related]
23. [Immunological data in the clinical evaluation of Hodgkin's diseases].
Burchardt K
Z Gesamte Inn Med; 1981 Nov; 36(21):840. PubMed ID: 6977241
[TBL] [Abstract][Full Text] [Related]
24. The effect of thymic substances on T circulating cells of patients treated for Hodgkin's disease.
Chisesi T; Capnist G; Rancan L; Pellizzari G; Vespignani M
J Biol Regul Homeost Agents; 1988; 2(4):193-8. PubMed ID: 3074627
[TBL] [Abstract][Full Text] [Related]
25. Management of advanced Hodgkin's disease in remission.
Klener P; Hausner P; Donner L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):213-7. PubMed ID: 6179821
[TBL] [Abstract][Full Text] [Related]
26. [Levamisole as an immunostimulating factor].
Smogorzewska E
Probl Med Wieku Rozwoj; 1979; 8():56-62. PubMed ID: 318115
[TBL] [Abstract][Full Text] [Related]
27. Immunologic status of children with Hodgkin's disease (HD).
Bogusławska-Jaworska J; Chybicka A; Pisarek J
Arch Immunol Ther Exp (Warsz); 1981; 29(6):725-31. PubMed ID: 6983869
[TBL] [Abstract][Full Text] [Related]
28. [State of cellular and humoral immunity in recurrent and chronic bronchopulmonary diseases in children before and after immunostimulation with levamisole].
Błaszczyk E; Kulczyk BA
Wiad Lek; 1985 Apr; 38(7):495-9. PubMed ID: 3874484
[No Abstract] [Full Text] [Related]
29. Depletion of circulating T lymphocytes in pregnancy.
Bulmer R; Hancock KW
Clin Exp Immunol; 1977 May; 28(2):302-5. PubMed ID: 301450
[TBL] [Abstract][Full Text] [Related]
30. [Levamisole correction of immunologic disorders in patients with lymphocytic leukemia].
Kozak VP
Vrach Delo; 1985 May; (5):74-7. PubMed ID: 3874479
[No Abstract] [Full Text] [Related]
31. Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients.
Pilarski LM; Mant MJ; Ruether BA; Belch A
J Clin Invest; 1984 Oct; 74(4):1301-6. PubMed ID: 6332828
[TBL] [Abstract][Full Text] [Related]
32. [Immunoregulatory subpopulations of T-lymphocytes and their distribution in the peripheral blood, lymph nodes and spleen of patients with lymphogranulomatosis].
Kharabadze MV; Tabagari DZ
Ter Arkh; 1989; 61(7):30-2. PubMed ID: 2686065
[TBL] [Abstract][Full Text] [Related]
33. [Effect of levamisole on cellular immunity indices in chronic bronchitis and chronic pneumonia patients].
Borisova AM; Novikova TA; Glazko AV
Ter Arkh; 1984; 56(10):29-31. PubMed ID: 6335306
[TBL] [Abstract][Full Text] [Related]
34. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
[TBL] [Abstract][Full Text] [Related]
35. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
Fisher RI
Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
[TBL] [Abstract][Full Text] [Related]
36. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
[TBL] [Abstract][Full Text] [Related]
37. Distinguishing features of the immunology of Hodgkin's disease in children.
Tan CT; De Sousa M; Good RA
Cancer Treat Rep; 1982 Apr; 66(4):969-75. PubMed ID: 7074657
[TBL] [Abstract][Full Text] [Related]
38. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
Basch CM; Spitler LE; Engleman EG; Engleman EP
J Rheumatol; 1977; 4(4):377-88. PubMed ID: 604477
[TBL] [Abstract][Full Text] [Related]
39. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
40. Ecotaxis: the principle and its application to the study of Hodgkin's disease.
Sousa MD; Yang M; Lopes-Corrales E; Tan C; Hansen JA; Dupont B; Good RA
Clin Exp Immunol; 1977 Jan; 27(1):143-51. PubMed ID: 300302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
